Literature DB >> 12161425

Regulation of reticuloendothelial iron transporter MTP1 (Slc11a3) by inflammation.

Funmei Yang1, Xiao-Bing Liu, Marlon Quinones, Peter C Melby, Andrew Ghio, David J Haile.   

Abstract

Acute and chronic inflammation cause many changes in total body iron metabolism including the sequestration of iron in phagocytic cells of the reticuloendothelial system. This change in iron metabolism contributes to the development of the anemia of inflammation. MTP1, the duodenal enterocyte basolateral iron exporter, is also expressed in the cells of the reticuloendothelial system (RES) and is likely to be involved in iron recycling of these cells. In this study, we use a lipopolysaccharide model of the acute inflammation in the mouse and demonstrate that MTP1 expression in RES cells of the spleen, liver, and bone marrow is down-regulated by inflammation. The down-regulation of splenic expression of MTP1 by inflammation was also observed in a Leishmania donovani model of chronic infection. The response of MTP1 to lipopolysaccharide (LPS) requires signaling through the LPS receptor, Toll-like receptor 4 (TLR4). In mice lacking TLR4, MTP1 expression is not altered in response to LPS. In addition, mice lacking tumor necrosis factor-receptor 1a respond appropriately to LPS with down-regulation of MTP1, despite hyporesponsiveness to tumor necrosis factor-alpha signaling, suggesting that this cytokine may not be required for the LPS effect. We hypothesize that the iron sequestration in the RES system that accompanies inflammation is because of down-regulation of MTP1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161425     DOI: 10.1074/jbc.M201485200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  58 in total

1.  β-Carotene can reverse dysregulation of iron protein in an in vitro model of inflammation.

Authors:  Oksana Katz; Ram Reifen; Aaron Lerner
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 2.  Iron homeostasis and the inflammatory response.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

3.  TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens.

Authors:  Carole Peyssonnaux; Annelies S Zinkernagel; Vivekanand Datta; Xavier Lauth; Randall S Johnson; Victor Nizet
Journal:  Blood       Date:  2006-01-03       Impact factor: 22.113

4.  Evidence for the multimeric structure of ferroportin.

Authors:  Ivana De Domenico; Diane McVey Ward; Giovanni Musci; Jerry Kaplan
Journal:  Blood       Date:  2006-10-31       Impact factor: 22.113

5.  A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia.

Authors:  Claudia Guida; Sandro Altamura; Felix A Klein; Bruno Galy; Michael Boutros; Artur J Ulmer; Matthias W Hentze; Martina U Muckenthaler
Journal:  Blood       Date:  2015-02-06       Impact factor: 22.113

6.  Rescuing iron-overloaded macrophages by conservative relocation of the accumulated metal.

Authors:  Yang-Sung Sohn; Anna-Maria Mitterstiller; William Breuer; Guenter Weiss; Z Ioav Cabantchik
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

7.  Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation.

Authors:  Zhaobao Yin; Haiyan Jiang; Eun-Sook Y Lee; Mingwei Ni; Keith M Erikson; Dejan Milatovic; Aaron B Bowman; Michael Aschner
Journal:  J Neurochem       Date:  2009-12-09       Impact factor: 5.372

Review 8.  The SLC40 basolateral iron transporter family (IREG1/ferroportin/MTP1).

Authors:  Andrew T McKie; David J Barlow
Journal:  Pflugers Arch       Date:  2003-06-27       Impact factor: 3.657

Review 9.  Manipulation of iron to determine survival: competition between host and pathogen.

Authors:  Nihay Laham; Rachel Ehrlich
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 10.  Iron, anaemia, and inflammatory bowel diseases.

Authors:  C Gasche; M C E Lomer; I Cavill; G Weiss
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.